The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
CADSET: Chronic Airway DiSeases Early sTratification
CRC Chairs: Alvar Agusti (Hospital Clinic de Barcelona, Respiratory Institute, University of Barcelona; Barcelona, Spain) Wisia Wedzicha (Imperial College London (ICL), London, United Kingdom)
/* Main content & Sidebar */ ?>
About CADSET
CADSET is a pan-European network committed to promoting clinical research in chronic airway diseases. The overarching working hypothesis of CADSET is that Asthma and Chronic Obstructive Pulmonary Disease (COPD) represent a continuum of heterogeneous chronic airway diseases that share clinical, functional, imaging and/or biological mechanisms (i.e endotypes), that can be identified by appropriately validated biomarkers, which may constitute novel therapeutic targets.
Multi-level (clinical, functional, imaging and molecular) profiling of well-characterized patients with chronic airways disease, spanning the spectrum of asthma and COPD, that considers both peak lung function achieved in early adulthood and the rate of lung function decline, may lead to the identification of distinct endotypes (and appropriate biomarkers) which may, in turn, inform a mechanism-based disease classification and a more personalized treatment of patients with chronic airways diseases.
Specific aims
To generate a multi-centre, multi-disciplinary platform that facilitates the investigation of lung function trajectories on the clinical presentation of chronic airway diseases.
To create a registry of currently available cohorts (and associated data and/or bio-banks) in order to launch joint meta-analyses.
To share expertise and resources, as well as create common research protocols to enable the comparison and integration of data across different cohorts.
To identify distinct biological mechanisms (i.e. endotypes), and associated biomarkers, underlying different lung function trajectories in order to move COPD assessment and therapy towards a precision medicine framework.
To raise public and private funding for these projects.
Membership
To achieve those aims five working groups have been composed and are the scientific drivers of CADSET.
WG1 – Registry: To develop a registry of sharable consortium resources (existing cohorts and data (clinical, imaging, samples, omics and bio-bank)) and to create common research protocols (SOP).
WG2 – From conception to 25 years: To investigate the phenotypes and endotypes of suboptimal peak lung function at early adulthood (<25 years).
WG3 – From 25 years to 50 years: To investigate the endotypes and clinical heterogeneity of early lung function decline as well as potential therapeutic responses (precision medicine).
WG4 – From 50 years onwards: Integrating multilevel data on well-defined populations with “asthma” or “COPD” in order to understand phenotypes, endotypes and biomarkers of chronic airway diseases.
WG5 – Building the long-life trajectories: To integrate the age-related results of WG2, WG3 and WG4.
Stakeholders
The Stakeholder Board offers an open forum composed by a strong and worthy partnership between the different stakeholders groups e.g clinician researchers, scientific experts, funding partners and patient advisors where project proposals and results are openly discussed. The Governance Committee forms the core deciding body of CADSET and is composed by the CRC Chairs, the Working Leads, patient and will drive the research agenda. An External international advisory board (EAB) of leading experts in the field will assess and input on the research agenda.
Bringing together the expertise of all these groups is certain to provide the means to achieve the goals of CADSET.
Contact
If you are interested in more information about CADSET or would like to join the network, please contact scientific@ersnet.org.
Financially supported by:
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies. However you may visit Cookie Settings to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.